These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20191584)

  • 41. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
    Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B
    Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
    Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
    J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of the B7-related molecule ICOSL by human glioma cells in vitro and in vivo.
    Schreiner B; Wischhusen J; Mitsdoerffer M; Schneider D; Bornemann A; Melms A; Tolosa E; Weller M; Wiendl H
    Glia; 2003 Dec; 44(3):296-301. PubMed ID: 14603470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
    Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
    J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ICOS: a new costimulatory ligand/receptor pair and its role in T-cell activion.
    Richter G; Burdach S
    Onkologie; 2004 Feb; 27(1):91-5. PubMed ID: 15007255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair.
    Ramavath NN; Gadipudi LL; Provera A; Gigliotti LC; Boggio E; Bozzola C; Albano E; Dianzani U; Sutti S
    Front Immunol; 2021; 12():786680. PubMed ID: 34925367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deep Flow Cytometry Unveils Distinct Immune Cell Subsets in Inducible T Cell Co-Stimulator Ligand (ICOSL)- and ICOS-Knockout Mice during Experimental Autoimmune Encephalomyelitis.
    Raineri D; Abreu H; Vilardo B; Kustrimovic N; Venegoni C; Cappellano G; Chiocchetti A
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of T-cell expansion caused by inducible costimulator/B7h costimulation blockade in direct allorecognition pathway.
    Du JF; Li QY; Ji XQ; Chen G; Bai X; Zuo FY; Yu B
    Transplant Proc; 2011 Dec; 43(10):3960-3. PubMed ID: 22172879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. B cell-specific expression of inducible costimulator ligand is necessary for the induction of arthritis in mice.
    Hamel KM; Cao Y; Olalekan SA; Finnegan A
    Arthritis Rheumatol; 2014 Jan; 66(1):60-7. PubMed ID: 24449576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective Role of ICOS and ICOS Ligand in Corneal Transplantation and in Maintenance of Immune Privilege.
    Kunishige T; Taniguchi H; Terada M; Akiba H; Yagita H; Abe R; Hori J
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6815-6823. PubMed ID: 28002569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural basis of inducible costimulator ligand costimulatory function: determination of the cell surface oligomeric state and functional mapping of the receptor binding site of the protein.
    Chattopadhyay K; Bhatia S; Fiser A; Almo SC; Nathenson SG
    J Immunol; 2006 Sep; 177(6):3920-9. PubMed ID: 16951355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity.
    Akbari O; Freeman GJ; Meyer EH; Greenfield EA; Chang TT; Sharpe AH; Berry G; DeKruyff RH; Umetsu DT
    Nat Med; 2002 Sep; 8(9):1024-32. PubMed ID: 12145647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reverse signaling using an inducible costimulator to enhance immunogenic function of dendritic cells.
    Tang G; Qin Q; Zhang P; Wang G; Liu M; Ding Q; Qin Y; Shen Q
    Cell Mol Life Sci; 2009 Sep; 66(18):3067-80. PubMed ID: 19603141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Attenuation of experimental autoimmune myocarditis by blocking activated T cells through inducible costimulatory molecule pathway.
    Futamatsu H; Suzuki J; Kosuge H; Yokoseki O; Kamada M; Ito H; Inobe M; Isobe M; Uede T
    Cardiovasc Res; 2003 Jul; 59(1):95-104. PubMed ID: 12829180
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of costimulation in antibody deficiencies: ICOS and common variable immunodeficiency.
    Yong PF; Salzer U; Grimbacher B
    Immunol Rev; 2009 May; 229(1):101-13. PubMed ID: 19426217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction.
    Rigas D; Lewis G; Aron JL; Wang B; Banie H; Sankaranarayanan I; Galle-Treger L; Maazi H; Lo R; Freeman GJ; Sharpe AH; Soroosh P; Akbari O
    J Allergy Clin Immunol; 2017 May; 139(5):1468-1477.e2. PubMed ID: 27717665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A functional role for inducible costimulator (ICOS) in atherosclerosis.
    Afek A; Harats D; Roth A; Keren G; George J
    Atherosclerosis; 2005 Nov; 183(1):57-63. PubMed ID: 15941568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prolonged xenograft survival induced by inducible costimulator-Ig is associated with increased forkhead box P3(+) cells.
    Hodgson R; Christiansen D; Ziolkowski A; Mouhtouris E; Simeonovic CJ; Ierino FL; Sandrin MS
    Transplantation; 2011 May; 91(10):1090-7. PubMed ID: 21544030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ICOS/ICOSL interaction is required for CD4+ invariant NKT cell function and homeostatic survival.
    Akbari O; Stock P; Meyer EH; Freeman GJ; Sharpe AH; Umetsu DT; DeKruyff RH
    J Immunol; 2008 Apr; 180(8):5448-56. PubMed ID: 18390727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Constitutive expression of the B7h ligand for inducible costimulator on naive B cells is extinguished after activation by distinct B cell receptor and interleukin 4 receptor-mediated pathways and can be rescued by CD40 signaling.
    Liang L; Porter EM; Sha WC
    J Exp Med; 2002 Jul; 196(1):97-108. PubMed ID: 12093874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.